{"entity":{"type":"insider","cik":"0001963878","url":"/insider/0001963878","json_url":"/insider/0001963878.json","name":"Bellon Christine","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":14,"first":"2023-04-05","last":"2026-04-06","span_basis":"filed_date"},"name_variants":[{"name":"Bellon Christine","source":"filing","n_filings":14,"first_seen":"2023-04-05","last_seen":"2026-04-06"}],"transactions":[{"id":6134543,"accession":"0001193125-26-144067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-144067","line_url":"/filing/0001193125-26-144067#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001963878","owner_name":"Bellon Christine","owner_display_name":"Bellon Christine","owner_url":"/insider/0001963878","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5956.0,"shares_display":"5,956","price_per_share":24.58,"price_display":"24.58","price_state":"stated","total_value":146398.48,"total_display":"146,398.48","total_whole":"146,398","shares_owned_after":109711.0,"shares_owned_after_display":"109,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-06","scope":"insider"},{"id":6228410,"accession":"0001193125-26-022557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-022557","line_url":"/filing/0001193125-26-022557#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001963878","owner_name":"Bellon Christine","owner_display_name":"Bellon Christine","owner_url":"/insider/0001963878","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1371.0,"shares_display":"1,371","price_per_share":34.0,"price_display":"34.00","price_state":"stated","total_value":46614.0,"total_display":"46,614.00","total_whole":"46,614","shares_owned_after":95667.0,"shares_owned_after_display":"95,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-22","filed_date":"2026-01-26","scope":"insider"},{"id":6110904,"accession":"0001193125-26-016552","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-016552","line_url":"/filing/0001193125-26-016552","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001963878","owner_name":"Bellon Christine","owner_display_name":"Bellon Christine","owner_url":"/insider/0001963878","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18629.0,"shares_display":"18,629","price_per_share":34.61439228622041,"price_display":"34.61","price_state":"stated","total_value":644831.5139,"total_display":"644,831.51","total_whole":"644,832","shares_owned_after":97597.0,"shares_owned_after_display":"97,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-15","filed_date":"2026-01-20","scope":"insider","n_lines":3},{"id":5821988,"accession":"0001193125-26-002427","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-002427","line_url":"/filing/0001193125-26-002427#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001963878","owner_name":"Bellon Christine","owner_display_name":"Bellon Christine","owner_url":"/insider/0001963878","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1254.0,"shares_display":"1,254","price_per_share":27.1,"price_display":"27.10","price_state":"stated","total_value":33983.4,"total_display":"33,983.40","total_whole":"33,983","shares_owned_after":115667.0,"shares_owned_after_display":"115,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-31","filed_date":"2026-01-05","scope":"insider"},{"id":4578278,"accession":"0001193125-25-230148","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-230148","line_url":"/filing/0001193125-25-230148#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001963878","owner_name":"Bellon Christine","owner_display_name":"Bellon Christine","owner_url":"/insider/0001963878","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":373.0,"shares_display":"373","price_per_share":24.53,"price_display":"24.53","price_state":"stated","total_value":9149.69,"total_display":"9,149.69","total_whole":"9,150","shares_owned_after":116921.0,"shares_owned_after_display":"116,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-01","filed_date":"2025-10-03","scope":"insider"},{"id":5074404,"accession":"0000950170-25-050859","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-050859","line_url":"/filing/0000950170-25-050859#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001963878","owner_name":"Bellon Christine","owner_display_name":"Bellon Christine","owner_url":"/insider/0001963878","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5674.0,"shares_display":"5,674","price_per_share":18.3507,"price_display":"18.35","price_state":"stated","total_value":104121.8718,"total_display":"104,121.87","total_whole":"104,122","shares_owned_after":117294.0,"shares_owned_after_display":"117,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-01","filed_date":"2025-04-03","scope":"insider"},{"id":5116862,"accession":"0000950170-25-023166","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-023166","line_url":"/filing/0000950170-25-023166#line-3","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001963878","owner_name":"Bellon Christine","owner_display_name":"Bellon Christine","owner_url":"/insider/0001963878","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":34.0,"price_display":"34.00","price_state":"stated","total_value":340000.0,"total_display":"340,000.00","total_whole":"340,000","shares_owned_after":102968.0,"shares_owned_after_display":"102,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-14","filed_date":"2025-02-19","scope":"insider"},{"id":4375450,"accession":"0000950170-25-002358","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-002358","line_url":"/filing/0000950170-25-002358#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001963878","owner_name":"Bellon Christine","owner_display_name":"Bellon Christine","owner_url":"/insider/0001963878","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1241.0,"shares_display":"1,241","price_per_share":24.68,"price_display":"24.68","price_state":"stated","total_value":30627.88,"total_display":"30,627.88","total_whole":"30,628","shares_owned_after":102968.0,"shares_owned_after_display":"102,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-02","filed_date":"2025-01-06","scope":"insider"},{"id":2177920,"accession":"0000950170-24-111739","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-111739","line_url":"/filing/0000950170-24-111739#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001963878","owner_name":"Bellon Christine","owner_display_name":"Bellon Christine","owner_url":"/insider/0001963878","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":385.0,"shares_display":"385","price_per_share":23.4794,"price_display":"23.48","price_state":"stated","total_value":9039.569,"total_display":"9,039.57","total_whole":"9,040","shares_owned_after":104209.0,"shares_owned_after_display":"104,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-01","filed_date":"2024-10-02","scope":"insider"},{"id":2416347,"accession":"0000950170-24-041438","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-041438","line_url":"/filing/0000950170-24-041438#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001963878","owner_name":"Bellon Christine","owner_display_name":"Bellon Christine","owner_url":"/insider/0001963878","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3401.0,"shares_display":"3,401","price_per_share":32.12,"price_display":"32.12","price_state":"stated","total_value":109240.12,"total_display":"109,240.12","total_whole":"109,240","shares_owned_after":104594.0,"shares_owned_after_display":"104,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider"},{"id":2175094,"accession":"0000950170-24-002480","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-002480","line_url":"/filing/0000950170-24-002480#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001963878","owner_name":"Bellon Christine","owner_display_name":"Bellon Christine","owner_url":"/insider/0001963878","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1907.0,"shares_display":"1,907","price_per_share":26.42,"price_display":"26.42","price_state":"stated","total_value":50382.94,"total_display":"50,382.94","total_whole":"50,383","shares_owned_after":80495.0,"shares_owned_after_display":"80,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-05","scope":"insider"},{"id":8724378,"accession":"0000950170-23-065868","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-23-065868","line_url":"/filing/0000950170-23-065868","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001963878","owner_name":"Bellon Christine","owner_display_name":"Bellon Christine","owner_url":"/insider/0001963878","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.5,"price_display":"30.50","price_state":"stated","total_value":305000.0,"total_display":"305,000.00","total_whole":"305,000","shares_owned_after":82402.0,"shares_owned_after_display":"82,402","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-22","scope":"insider","n_lines":2},{"id":8011985,"accession":"0000950170-23-051915","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-051915","line_url":"/filing/0000950170-23-051915#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001963878","owner_name":"Bellon Christine","owner_display_name":"Bellon Christine","owner_url":"/insider/0001963878","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":388.0,"shares_display":"388","price_per_share":22.85,"price_display":"22.85","price_state":"stated","total_value":8865.8,"total_display":"8,865.80","total_whole":"8,866","shares_owned_after":82402.0,"shares_owned_after_display":"82,402","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-02","filed_date":"2023-10-04","scope":"insider"},{"id":7939230,"accession":"0000899243-23-010817","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-010817","line_url":"/filing/0000899243-23-010817#line-2","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001963878","owner_name":"Bellon Christine","owner_display_name":"Bellon Christine","owner_url":"/insider/0001963878","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1161.0,"shares_display":"1,161","price_per_share":29.0931,"price_display":"29.09","price_state":"stated","total_value":33777.0891,"total_display":"33,777.09","total_whole":"33,777","shares_owned_after":82790.0,"shares_owned_after_display":"82,790","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-04","filed_date":"2023-04-05","scope":"insider"},{"id":7939227,"accession":"0000899243-23-010817","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-010817","line_url":"/filing/0000899243-23-010817#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001963878","owner_name":"Bellon Christine","owner_display_name":"Bellon Christine","owner_url":"/insider/0001963878","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":931.0,"shares_display":"931","price_per_share":30.31,"price_display":"30.31","price_state":"stated","total_value":28218.61,"total_display":"28,218.61","total_whole":"28,219","shares_owned_after":83951.0,"shares_owned_after_display":"83,951","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001745999","name":"Beam Therapeutics Inc.","url":"/issuer/0001745999","role":"Officer (Chief Legal Officer)","n_filings":14,"first_seen":"2023-04-05","last_seen":"2026-04-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001963878","retrieved_at":"2026-08-24T18:13:59+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}